The Valley Desk

NCT02371980 · Interventional trial

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

Overall registry status Completed

Phase 4

Conditions Major Depressive Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov